Literature DB >> 9766921

Severe infection caused by Stomatococcus mucilaginosus in a neutropenic patient: case report and review of the literature.

D Gruson1, G Hilbert, A Pigneux, F Vargas, O Guisset, J Texier, J M Boiron, J Reiffers, G Gbikpi-Benissan, J P Cardinaud.   

Abstract

A 24-year-old female, in neutropenic phase after chemotherapy for acute myelogenous leukemia (on day 15) was admitted in intensive care unit for infectious pneumonia. Two strains of Stomatococcus mucilaginosus were isolated from peripheral blood cultures. No microorganisms were yielded from bronchoalveolar lavage. Patient's condition improved with prompt instigation of effective antibiotic therapy. This was the first case of septicemia and pneumonia, due to Stomatococcus mucilaginosus, in our unit. Only 26 cases occurring in neutropenic patients with underlying hematologic malignancies were reported in the literature and among these, only five cases with pneumonia were described. The complications of this normal inhabitant of the human oral cavity can be serious and fatal: septic shock, meningitis, acute respiratory distress syndrome. This study illustrate the possible virulence of Stomatococcus mucilaginosus in neutropenic patients.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9766921

Source DB:  PubMed          Journal:  Hematol Cell Ther        ISSN: 1269-3286


  2 in total

1.  Antimicrobial effects of the saliva substitute, Oralbalance, against microorganisms from oral mucosa in the hematopoietic cell transplantation period.

Authors:  Yuko Sugiura; Yoshihiko Soga; Ichiro Tanimoto; Susumu Kokeguchi; Sachiko Nishide; Kotoe Kono; Kanayo Takahashi; Nobuharu Fujii; Fumihiko Ishimaru; Mitsune Tanimoto; Kokoro Yamabe; Soichiro Tsutani; Fusanori Nishimura; Shogo Takashiba
Journal:  Support Care Cancer       Date:  2008-01-16       Impact factor: 3.603

2.  Rothia mucilaginosa prosthetic device infections: a case of prosthetic valve endocarditis.

Authors:  Jackrapong Bruminhent; Mindy J Tokarczyk; Donald Jungkind; Joseph A DeSimone
Journal:  J Clin Microbiol       Date:  2013-03-06       Impact factor: 5.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.